2025-01-20 2026-01-31 true No description of principal activity Acting Office - Tax and Accounts 1.0 16195197 bus:FullAccounts 2025-01-20 2026-01-31 16195197 bus:Micro-entities 2025-01-20 2026-01-31 16195197 bus:AuditExempt-NoAccountantsReport 2025-01-20 2026-01-31 16195197 bus:SmallCompaniesRegimeForAccounts 2025-01-20 2026-01-31 16195197 bus:PrivateLimitedCompanyLtd 2025-01-20 2026-01-31 16195197 2025-01-20 2026-01-31 16195197 2026-01-31 16195197 bus:RegisteredOffice 2025-01-20 2026-01-31 16195197 core:WithinOneYear 2026-01-31 16195197 core:AfterOneYear 2026-01-31 16195197 2024-01-20 16195197 bus:Director1 2025-01-20 2026-01-31 16195197 bus:Director1 2026-01-31 16195197 bus:Director2 2025-01-20 2026-01-31 16195197 bus:Director2 2026-01-31 16195197 bus:CompanySecretary1 2025-01-20 2026-01-31 16195197 bus:LeadAgentIfApplicable 2025-01-20 2026-01-31 16195197 2025-01-19 16195197 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 16195197 core:CostValuation core:Non-currentFinancialInstruments 2025-01-19 16195197 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 16195197 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16195197 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16195197 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16195197 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-01-31 16195197 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-01-31 16195197 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16195197 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16195197 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16195197 core:Non-currentFinancialInstruments 2026-01-31 16195197 core:Non-currentFinancialInstruments 2025-01-19 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 16195197
England and Wales

 

 

 

KALLISTOS HOUSE AESTHETICS CLINIC LIMITED


Dormant Accounts
 


Period of accounts

Start date : 20 January 2025

End date : 31 January 2026
Directors Annette Kathy-Anne Hall-Tuitt
Stephen Gerad Tuitt
Registered Number 16195197
Registered Office 51 Oxford Street
Kallistos House
Wellingborough
Northamptonshire
NN8 4JH
1
 
 
2026
£
 
Current assets 6 
Net current assets/(liabilities) 6 
Total assets less current liabilities 6 
Net assets/(liabilities) 6 
 
Capital and reserves 6 
 



Notes to the Accounts

For the period ended 31 January 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' Responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Signed on behalf of the board of directors:


---------------------------------------------
Annette Kathy-Anne Hall-Tuitt
Director

Date approved: 19 October 2026
2